ArticleCancer science2023

Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING-dependent therapy-induced senescence and provides "one-two punch" opportunity with anti-PD-L1 therapy in colorectal cancer.

Tao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.